C9 and amyotrophic lateral sclerosis: In addition, an isogenic control iPSC line (CS29-ISO) was established by the CRISPR/Cas9-mediated deletion of the hexanucleotide repeat expansion in one of these C9-ALS iPSC lines (C9-ALS CS29) [80].